UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002152 |
|---|---|
| Receipt number | R000002632 |
| Scientific Title | A phase 1 study of combination therapy with gemcitabine and candesartan in patients with pancreatic cancer |
| Date of disclosure of the study information | 2009/07/01 |
| Last modified on | 2015/12/11 08:20:32 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/07/01 20:27:00 | ||
| 2 | Update | 2009/07/04 09:31:26 | Key exclusion criteria Key exclusion criteria |
|
| 3 | Update | 2010/01/07 12:49:45 | Recruitment status |
|
| 4 | Update | 2011/01/01 09:31:39 | Recruitment status |
|
| 5 | Update | 2011/07/01 10:46:12 | Name of person sending information Organization Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 6 | Update | 2011/07/01 10:47:20 | Publication of results |
|
| 7 | Update | 2012/01/01 09:02:26 | Last follow-up date |
|
| 8 | Update | 2012/07/01 09:01:41 | Recruitment status Publication of results |
|
| 9 | Update | 2015/12/11 08:20:32 | Recruitment status Other related information |
